Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts

To explore the local mechanisms of fibroblast growth factor (FGF) 23 regulations, we examined the FGF23 expression patterns in an osteoblast culture model. The characteristics of cultured rat calvaria osteoblasts in half-confluence, confluence, osteoid deposition, and osteoid mineralization stages m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Calcified tissue international 2010-05, Vol.86 (5), p.404-410
Hauptverfasser: Tang, Wen-Jing, Wang, Li-Fang, Xu, Xiao-Ya, Zhou, Yi, Jin, Wei-Fang, Wang, Hong-Fu, Gao, Jianjun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 410
container_issue 5
container_start_page 404
container_title Calcified tissue international
container_volume 86
creator Tang, Wen-Jing
Wang, Li-Fang
Xu, Xiao-Ya
Zhou, Yi
Jin, Wei-Fang
Wang, Hong-Fu
Gao, Jianjun
description To explore the local mechanisms of fibroblast growth factor (FGF) 23 regulations, we examined the FGF23 expression patterns in an osteoblast culture model. The characteristics of cultured rat calvaria osteoblasts in half-confluence, confluence, osteoid deposition, and osteoid mineralization stages might reflect the proliferation, differentiation, maturation, and matrix mineralization stages, respectively. Compared with proliferating cells in half-confluence, FGF23 expression was upregulated by 7.5-fold at the mRNA level and 126% at the protein level in confluent differentiated cells as determined by real-time RT-PCR and Western blot analysis. Interestingly, mRNA levels of CYP27B1 (the gene coding for 1α-hydroxylase enzyme which catalyses the conversion of 1α,25-dihydroxyvitamin D, 1α,25[OH] 2 D, from its inactive form, 25-hydroxycholecalciferol, 25[OH]D) and CYP24A (the gene coding for 24-hydroxylase, a target gene of 1α,25[OH] 2 D) were significantly increased by twofold and 34-fold, respectively, in differentiated osteoblasts compared with proliferating cells. We next examined if the local production of 1α,25(OH) 2 D might contribute to the FGF23 upregulation. We cultured osteoblasts in serum-free medium with or without 25-(OH)D (the substrate of 1α-hydroxylase). FGF23 mRNA levels were increased in proliferating cells (16-fold) and in differentiated cells (28-fold) by the physiological dose of 25-(OH)D 3 treatment. CYP27B1 was slightly but significantly upregulated and CYP24A was increased by 1,700-fold and 800-fold, respectively, in transcriptional levels. Because FGF23 was upregulated in confluent osteoblasts regardless of the presence or absence of 25-(OH)D in serum-free medium, we further examined the possible impact of cell communication on FGF23 expression. We treated osteoblasts with carbenoxolone, a gap junction Cx43 blocker in serum-free medium. The FGF23 mRNA level was reduced by 50% in confluent differentiated cells and slightly but not significantly reduced in half-confluent cells by carbenoxolone treatments. The results suggested that upregulation of FGF23 in differentiated osteoblast appeared to be due to increased autocrine/paracrine action of osteoblast-derived 1α,25(OH) 2 D and increased cell communication, which were identified in cultured rat calvaria osteoblasts. These results indicate that FGF23 expression was stimulated not only by circulating calcitriol but also by locally produced 1α,25(OH) 2 D. The local mechanisms of FGF23 expre
doi_str_mv 10.1007/s00223-010-9355-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745975026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2017516901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-8fb67103161a48c58cf0d6e15ae53b104186d50278cf58c1ea281bdf712c4ff73</originalsourceid><addsrcrecordid>eNqFkctKxDAUhoMoOl4ewI0UN66q5yTNpcthdEZBUMTbLqRtKpVOOyYp6NubcbyAIK6S8H_5DoefkH2EYwSQJx6AUpYCQpozzlO6RkaYMZqConKdjAAlprmQj1tk2_tnAMyEEJtkiwLjmVB0RB7GQ-hL13T25No483FLxmVo-i7p6-S-CWbedMlpEt_T2ZSy5Ox14az3SyAGk6ENg7NVcmNCcuWD7YvW-OB3yUZtWm_3Ps8dcjc9u52cp5dXs4vJ-DIt4_yQqroQEoGhQJOpkquyhkpY5MZyViBkqETFgcoYxBCtoQqLqpZIy6yuJdshRyvvwvUvg_VBzxtf2rY1ne0Hr2XGcxkF4n-SsRxUrmgkD3-Rz_3guriGpkhzjpGMEK6g0vXeO1vrhWvmxr1pBL1sR6_a0bEdvWxHL8UHn-KhmNvq-8dXHRGgK8DHqHuy7mfy39Z3qImX0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212951339</pqid></control><display><type>article</type><title>Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Tang, Wen-Jing ; Wang, Li-Fang ; Xu, Xiao-Ya ; Zhou, Yi ; Jin, Wei-Fang ; Wang, Hong-Fu ; Gao, Jianjun</creator><creatorcontrib>Tang, Wen-Jing ; Wang, Li-Fang ; Xu, Xiao-Ya ; Zhou, Yi ; Jin, Wei-Fang ; Wang, Hong-Fu ; Gao, Jianjun</creatorcontrib><description>To explore the local mechanisms of fibroblast growth factor (FGF) 23 regulations, we examined the FGF23 expression patterns in an osteoblast culture model. The characteristics of cultured rat calvaria osteoblasts in half-confluence, confluence, osteoid deposition, and osteoid mineralization stages might reflect the proliferation, differentiation, maturation, and matrix mineralization stages, respectively. Compared with proliferating cells in half-confluence, FGF23 expression was upregulated by 7.5-fold at the mRNA level and 126% at the protein level in confluent differentiated cells as determined by real-time RT-PCR and Western blot analysis. Interestingly, mRNA levels of CYP27B1 (the gene coding for 1α-hydroxylase enzyme which catalyses the conversion of 1α,25-dihydroxyvitamin D, 1α,25[OH] 2 D, from its inactive form, 25-hydroxycholecalciferol, 25[OH]D) and CYP24A (the gene coding for 24-hydroxylase, a target gene of 1α,25[OH] 2 D) were significantly increased by twofold and 34-fold, respectively, in differentiated osteoblasts compared with proliferating cells. We next examined if the local production of 1α,25(OH) 2 D might contribute to the FGF23 upregulation. We cultured osteoblasts in serum-free medium with or without 25-(OH)D (the substrate of 1α-hydroxylase). FGF23 mRNA levels were increased in proliferating cells (16-fold) and in differentiated cells (28-fold) by the physiological dose of 25-(OH)D 3 treatment. CYP27B1 was slightly but significantly upregulated and CYP24A was increased by 1,700-fold and 800-fold, respectively, in transcriptional levels. Because FGF23 was upregulated in confluent osteoblasts regardless of the presence or absence of 25-(OH)D in serum-free medium, we further examined the possible impact of cell communication on FGF23 expression. We treated osteoblasts with carbenoxolone, a gap junction Cx43 blocker in serum-free medium. The FGF23 mRNA level was reduced by 50% in confluent differentiated cells and slightly but not significantly reduced in half-confluent cells by carbenoxolone treatments. The results suggested that upregulation of FGF23 in differentiated osteoblast appeared to be due to increased autocrine/paracrine action of osteoblast-derived 1α,25(OH) 2 D and increased cell communication, which were identified in cultured rat calvaria osteoblasts. These results indicate that FGF23 expression was stimulated not only by circulating calcitriol but also by locally produced 1α,25(OH) 2 D. The local mechanisms of FGF23 expression remain to be characterized.</description><identifier>ISSN: 0171-967X</identifier><identifier>EISSN: 1432-0827</identifier><identifier>DOI: 10.1007/s00223-010-9355-2</identifier><identifier>PMID: 20354682</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Animals ; Animals, Newborn ; Autocrine Communication - drug effects ; Autocrine Communication - physiology ; Biochemistry ; Biomedical and Life Sciences ; Blotting, Western ; Calcitriol - pharmacology ; Carbenoxolone - pharmacology ; Cell Biology ; Cell Proliferation - drug effects ; Cells ; Cells, Cultured ; Endocrinology ; Fibroblast Growth Factors - genetics ; Fibroblast Growth Factors - metabolism ; Gene Expression - drug effects ; Life Sciences ; Orthopedics ; Osteoblasts - drug effects ; Osteoblasts - metabolism ; Paracrine Communication - drug effects ; Paracrine Communication - physiology ; Rats ; Rats, Sprague-Dawley ; Ribonucleic acid ; RNA ; RNA, Messenger - metabolism ; Rodents ; Skull - cytology ; Up-Regulation - drug effects ; Vitamin D</subject><ispartof>Calcified tissue international, 2010-05, Vol.86 (5), p.404-410</ispartof><rights>Springer Science+Business Media, LLC 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-8fb67103161a48c58cf0d6e15ae53b104186d50278cf58c1ea281bdf712c4ff73</citedby><cites>FETCH-LOGICAL-c468t-8fb67103161a48c58cf0d6e15ae53b104186d50278cf58c1ea281bdf712c4ff73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00223-010-9355-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00223-010-9355-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20354682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Wen-Jing</creatorcontrib><creatorcontrib>Wang, Li-Fang</creatorcontrib><creatorcontrib>Xu, Xiao-Ya</creatorcontrib><creatorcontrib>Zhou, Yi</creatorcontrib><creatorcontrib>Jin, Wei-Fang</creatorcontrib><creatorcontrib>Wang, Hong-Fu</creatorcontrib><creatorcontrib>Gao, Jianjun</creatorcontrib><title>Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts</title><title>Calcified tissue international</title><addtitle>Calcif Tissue Int</addtitle><addtitle>Calcif Tissue Int</addtitle><description>To explore the local mechanisms of fibroblast growth factor (FGF) 23 regulations, we examined the FGF23 expression patterns in an osteoblast culture model. The characteristics of cultured rat calvaria osteoblasts in half-confluence, confluence, osteoid deposition, and osteoid mineralization stages might reflect the proliferation, differentiation, maturation, and matrix mineralization stages, respectively. Compared with proliferating cells in half-confluence, FGF23 expression was upregulated by 7.5-fold at the mRNA level and 126% at the protein level in confluent differentiated cells as determined by real-time RT-PCR and Western blot analysis. Interestingly, mRNA levels of CYP27B1 (the gene coding for 1α-hydroxylase enzyme which catalyses the conversion of 1α,25-dihydroxyvitamin D, 1α,25[OH] 2 D, from its inactive form, 25-hydroxycholecalciferol, 25[OH]D) and CYP24A (the gene coding for 24-hydroxylase, a target gene of 1α,25[OH] 2 D) were significantly increased by twofold and 34-fold, respectively, in differentiated osteoblasts compared with proliferating cells. We next examined if the local production of 1α,25(OH) 2 D might contribute to the FGF23 upregulation. We cultured osteoblasts in serum-free medium with or without 25-(OH)D (the substrate of 1α-hydroxylase). FGF23 mRNA levels were increased in proliferating cells (16-fold) and in differentiated cells (28-fold) by the physiological dose of 25-(OH)D 3 treatment. CYP27B1 was slightly but significantly upregulated and CYP24A was increased by 1,700-fold and 800-fold, respectively, in transcriptional levels. Because FGF23 was upregulated in confluent osteoblasts regardless of the presence or absence of 25-(OH)D in serum-free medium, we further examined the possible impact of cell communication on FGF23 expression. We treated osteoblasts with carbenoxolone, a gap junction Cx43 blocker in serum-free medium. The FGF23 mRNA level was reduced by 50% in confluent differentiated cells and slightly but not significantly reduced in half-confluent cells by carbenoxolone treatments. The results suggested that upregulation of FGF23 in differentiated osteoblast appeared to be due to increased autocrine/paracrine action of osteoblast-derived 1α,25(OH) 2 D and increased cell communication, which were identified in cultured rat calvaria osteoblasts. These results indicate that FGF23 expression was stimulated not only by circulating calcitriol but also by locally produced 1α,25(OH) 2 D. The local mechanisms of FGF23 expression remain to be characterized.</description><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Autocrine Communication - drug effects</subject><subject>Autocrine Communication - physiology</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Blotting, Western</subject><subject>Calcitriol - pharmacology</subject><subject>Carbenoxolone - pharmacology</subject><subject>Cell Biology</subject><subject>Cell Proliferation - drug effects</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Endocrinology</subject><subject>Fibroblast Growth Factors - genetics</subject><subject>Fibroblast Growth Factors - metabolism</subject><subject>Gene Expression - drug effects</subject><subject>Life Sciences</subject><subject>Orthopedics</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - metabolism</subject><subject>Paracrine Communication - drug effects</subject><subject>Paracrine Communication - physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA, Messenger - metabolism</subject><subject>Rodents</subject><subject>Skull - cytology</subject><subject>Up-Regulation - drug effects</subject><subject>Vitamin D</subject><issn>0171-967X</issn><issn>1432-0827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkctKxDAUhoMoOl4ewI0UN66q5yTNpcthdEZBUMTbLqRtKpVOOyYp6NubcbyAIK6S8H_5DoefkH2EYwSQJx6AUpYCQpozzlO6RkaYMZqConKdjAAlprmQj1tk2_tnAMyEEJtkiwLjmVB0RB7GQ-hL13T25No483FLxmVo-i7p6-S-CWbedMlpEt_T2ZSy5Ox14az3SyAGk6ENg7NVcmNCcuWD7YvW-OB3yUZtWm_3Ps8dcjc9u52cp5dXs4vJ-DIt4_yQqroQEoGhQJOpkquyhkpY5MZyViBkqETFgcoYxBCtoQqLqpZIy6yuJdshRyvvwvUvg_VBzxtf2rY1ne0Hr2XGcxkF4n-SsRxUrmgkD3-Rz_3guriGpkhzjpGMEK6g0vXeO1vrhWvmxr1pBL1sR6_a0bEdvWxHL8UHn-KhmNvq-8dXHRGgK8DHqHuy7mfy39Z3qImX0A</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Tang, Wen-Jing</creator><creator>Wang, Li-Fang</creator><creator>Xu, Xiao-Ya</creator><creator>Zhou, Yi</creator><creator>Jin, Wei-Fang</creator><creator>Wang, Hong-Fu</creator><creator>Gao, Jianjun</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100501</creationdate><title>Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts</title><author>Tang, Wen-Jing ; Wang, Li-Fang ; Xu, Xiao-Ya ; Zhou, Yi ; Jin, Wei-Fang ; Wang, Hong-Fu ; Gao, Jianjun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-8fb67103161a48c58cf0d6e15ae53b104186d50278cf58c1ea281bdf712c4ff73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Autocrine Communication - drug effects</topic><topic>Autocrine Communication - physiology</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Blotting, Western</topic><topic>Calcitriol - pharmacology</topic><topic>Carbenoxolone - pharmacology</topic><topic>Cell Biology</topic><topic>Cell Proliferation - drug effects</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Endocrinology</topic><topic>Fibroblast Growth Factors - genetics</topic><topic>Fibroblast Growth Factors - metabolism</topic><topic>Gene Expression - drug effects</topic><topic>Life Sciences</topic><topic>Orthopedics</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - metabolism</topic><topic>Paracrine Communication - drug effects</topic><topic>Paracrine Communication - physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA, Messenger - metabolism</topic><topic>Rodents</topic><topic>Skull - cytology</topic><topic>Up-Regulation - drug effects</topic><topic>Vitamin D</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Wen-Jing</creatorcontrib><creatorcontrib>Wang, Li-Fang</creatorcontrib><creatorcontrib>Xu, Xiao-Ya</creatorcontrib><creatorcontrib>Zhou, Yi</creatorcontrib><creatorcontrib>Jin, Wei-Fang</creatorcontrib><creatorcontrib>Wang, Hong-Fu</creatorcontrib><creatorcontrib>Gao, Jianjun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Calcified tissue international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Wen-Jing</au><au>Wang, Li-Fang</au><au>Xu, Xiao-Ya</au><au>Zhou, Yi</au><au>Jin, Wei-Fang</au><au>Wang, Hong-Fu</au><au>Gao, Jianjun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts</atitle><jtitle>Calcified tissue international</jtitle><stitle>Calcif Tissue Int</stitle><addtitle>Calcif Tissue Int</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>86</volume><issue>5</issue><spage>404</spage><epage>410</epage><pages>404-410</pages><issn>0171-967X</issn><eissn>1432-0827</eissn><abstract>To explore the local mechanisms of fibroblast growth factor (FGF) 23 regulations, we examined the FGF23 expression patterns in an osteoblast culture model. The characteristics of cultured rat calvaria osteoblasts in half-confluence, confluence, osteoid deposition, and osteoid mineralization stages might reflect the proliferation, differentiation, maturation, and matrix mineralization stages, respectively. Compared with proliferating cells in half-confluence, FGF23 expression was upregulated by 7.5-fold at the mRNA level and 126% at the protein level in confluent differentiated cells as determined by real-time RT-PCR and Western blot analysis. Interestingly, mRNA levels of CYP27B1 (the gene coding for 1α-hydroxylase enzyme which catalyses the conversion of 1α,25-dihydroxyvitamin D, 1α,25[OH] 2 D, from its inactive form, 25-hydroxycholecalciferol, 25[OH]D) and CYP24A (the gene coding for 24-hydroxylase, a target gene of 1α,25[OH] 2 D) were significantly increased by twofold and 34-fold, respectively, in differentiated osteoblasts compared with proliferating cells. We next examined if the local production of 1α,25(OH) 2 D might contribute to the FGF23 upregulation. We cultured osteoblasts in serum-free medium with or without 25-(OH)D (the substrate of 1α-hydroxylase). FGF23 mRNA levels were increased in proliferating cells (16-fold) and in differentiated cells (28-fold) by the physiological dose of 25-(OH)D 3 treatment. CYP27B1 was slightly but significantly upregulated and CYP24A was increased by 1,700-fold and 800-fold, respectively, in transcriptional levels. Because FGF23 was upregulated in confluent osteoblasts regardless of the presence or absence of 25-(OH)D in serum-free medium, we further examined the possible impact of cell communication on FGF23 expression. We treated osteoblasts with carbenoxolone, a gap junction Cx43 blocker in serum-free medium. The FGF23 mRNA level was reduced by 50% in confluent differentiated cells and slightly but not significantly reduced in half-confluent cells by carbenoxolone treatments. The results suggested that upregulation of FGF23 in differentiated osteoblast appeared to be due to increased autocrine/paracrine action of osteoblast-derived 1α,25(OH) 2 D and increased cell communication, which were identified in cultured rat calvaria osteoblasts. These results indicate that FGF23 expression was stimulated not only by circulating calcitriol but also by locally produced 1α,25(OH) 2 D. The local mechanisms of FGF23 expression remain to be characterized.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>20354682</pmid><doi>10.1007/s00223-010-9355-2</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0171-967X
ispartof Calcified tissue international, 2010-05, Vol.86 (5), p.404-410
issn 0171-967X
1432-0827
language eng
recordid cdi_proquest_miscellaneous_745975026
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Animals
Animals, Newborn
Autocrine Communication - drug effects
Autocrine Communication - physiology
Biochemistry
Biomedical and Life Sciences
Blotting, Western
Calcitriol - pharmacology
Carbenoxolone - pharmacology
Cell Biology
Cell Proliferation - drug effects
Cells
Cells, Cultured
Endocrinology
Fibroblast Growth Factors - genetics
Fibroblast Growth Factors - metabolism
Gene Expression - drug effects
Life Sciences
Orthopedics
Osteoblasts - drug effects
Osteoblasts - metabolism
Paracrine Communication - drug effects
Paracrine Communication - physiology
Rats
Rats, Sprague-Dawley
Ribonucleic acid
RNA
RNA, Messenger - metabolism
Rodents
Skull - cytology
Up-Regulation - drug effects
Vitamin D
title Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T10%3A21%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autocrine/Paracrine%20Action%20of%20Vitamin%20D%20on%20FGF23%20Expression%20in%20Cultured%20Rat%20Osteoblasts&rft.jtitle=Calcified%20tissue%20international&rft.au=Tang,%20Wen-Jing&rft.date=2010-05-01&rft.volume=86&rft.issue=5&rft.spage=404&rft.epage=410&rft.pages=404-410&rft.issn=0171-967X&rft.eissn=1432-0827&rft_id=info:doi/10.1007/s00223-010-9355-2&rft_dat=%3Cproquest_cross%3E2017516901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212951339&rft_id=info:pmid/20354682&rfr_iscdi=true